Develop the most competitive and focused pipeline to address unmet patient needs in a highly differentiated way to drive the growth of Teva
Establish leadership in
Build a unique platform for
Sustain and leverage strength in
Achieve leading presence in
Selectively Invest
NTE - New Therapeutic Entity
Known molecules that are formulated, delivered, or used in a novel way to address unmet patient needs
World leading expert on Huntington Disease
Killam Professor of Medical Genetics and Canada Research Chair in Human Genetics and Molecular Medicine, University of British Columbia
Founder and Director/Senior Scientist, Centre for Molecular Medicine and Therapeutics, University of British Columbia
Founder, biotechnology companies: NeuroVir; Aspreva Pharmaceuticals; Xenon Pharmaceuticals Inc.
Training in Internal Medicine, post-doctoral fellowship Harvard Medical School
Former EVP, head of Medical & Regulatory Medpace
Training in Internal Medicine and Cardiology Harvard Medical School
Member of the cardiology faculty Yale Medical School
Co-founder Metabolic & Atherosclerosis Research Center, Cincinnati
US Board certified neurologist Neurology residence at Yale Medical School
15 years of pharma experience Bayer, Medimmune/AZ
Most recent position: Head of Clinical Development, Neurology Medimmune/AZ
